Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo (Q34722085)
Jump to navigation
Jump to search
scientific article published on October 23, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo |
scientific article published on October 23, 2010 |
Statements
1 reference
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo (English)
1 reference
Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo (English)
1 reference
Grace A McComsey
1 reference
Nesrine Rizk
Vikram Dogra
Marisa Tungsiripat
1 reference
Dalia El-Bejjani
1 reference
Mary Ann O'Riordan
1 reference
Corrilynn Hileman
1 reference
Norma Storer
1 reference
Danielle Harrill
1 reference
Allison C. Ross
23 October 2010
1 reference
1 reference
27
1 reference
3
1 reference
295-302
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference